Related Experiment Videos

[Congenital tuberculosis in a premature infant]

H G Limbach1, H J Jesberger, G Löffler

  • 1Universitätsklinik für Kinder- und Jugendmedizin Homburg/Saar.

Klinische Padiatrie
|January 1, 1993
PubMed

Insights

Congenital tuberculosis in a premature infant was diagnosed via stomach secretion analysis. Treatment with isoniazid and rifampicin successfully cured the infection, despite streptomycin resistance and developing cholestasis.

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Pediatric Tuberculosis

Background:

  • Congenital tuberculosis is a rare but severe condition in newborns.
  • Early diagnosis and prompt treatment are crucial for patient survival.

Observation:

  • A premature infant (31 weeks gestation, 1300g) presented with suspected congenital tuberculosis at 5 days old.
  • Mycobacterium tuberculosis was identified in gastric aspirates, correlating with abdominal symptoms and anemia.

Findings:

  • The infant received a 3-month dual parenteral therapy (isoniazid and rifampicin) followed by 6 months of isoniazid monotherapy.
  • The tuberculosis was successfully treated, although the Mycobacterium tuberculosis strain developed resistance to streptomycin.
  • Cholestasis emerged as a complication during the initial phase of chemotherapy.

Implications:

  • This case highlights the importance of considering congenital tuberculosis in at-risk neonates.
  • Effective treatment regimens for congenital tuberculosis can be achieved with appropriate antibiotic selection.
  • Monitoring for drug resistance and treatment-related complications like cholestasis is essential.

Related Concept Videos